COVID-19 convalescent plasma cohort study: evaluation of the association between both donor and recipient neutralizing antibody titers and patient outcomes (2021)
- Authors:
- Yokoyama, Ana Paula Hitomi
- Wendel, Silvano
- Bub, Carolina Bonet
- Fachini, Roberta M.
- Dametto, Ana Paula F.
- Blumm, Fernando
- Dutra, Valeria F.
- Candelaria, Gabriela T. P.
- Sakashita, Araci M.
- Machado, Rafael Rahal Guaragna
- Wendel, Rita Fontão
- Hamerschlak, Nelson
- Achkar, Ruth
- Assunção, Murillo Santucci Cesar
- Scuracchio, Patrícia
- Nudelman, Victor
- Pastore, Laerte
- Pinho, João R. R.
- Ben, Mirian Dal
- Kalil Filho, Roberto
- Marra, Alexandre R.
- Amano, Mariane T.
- Kallás, Esper Georges
- Helito, Alfredo Salim
- Carvalho, Carlos Roberto Ribeiro De
- Araujo, Danielle Bastos
- Durigon, Edison Luiz
- Camargo, Anamaria Aranha
- Rizzo, Luiz V.
- Reis, Luiz F. L.
- Kutner, José Mauro
- USP affiliated authors: KALIL FILHO, ROBERTO - FM ; KALLAS, ESPER GEORGES - FM ; CARVALHO, CARLOS ROBERTO RIBEIRO DE - FM ; DURIGON, EDISON LUIZ - ICB ; MACHADO, RAFAEL RAHAL GUARAGNA - ICB
- Unidades: FM; ICB
- DOI: 10.1111/trf.16573
- Subjects: MICROBIOLOGIA; COVID-19; TRANSFUSÃO DE SANGUE; PLASMA; ANTICORPOS; ESTUDOS DE COORTES; PACIENTES; UNIDADES DE TERAPIA INTENSIVA
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Transfusion
- ISSN: 1537-2995
- Volume/Número/Paginação/Ano: p. 1-12, 2021
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: green
- Licença: unspecified-oa
-
ABNT
YOKOYAMA, Ana Paula Hitomi et al. COVID-19 convalescent plasma cohort study: evaluation of the association between both donor and recipient neutralizing antibody titers and patient outcomes. Transfusion, p. 1-12, 2021Tradução . . Disponível em: https://doi.org/10.1111/trf.16573. Acesso em: 02 maio 2024. -
APA
Yokoyama, A. P. H., Wendel, S., Bub, C. B., Fachini, R. M., Dametto, A. P. F., Blumm, F., et al. (2021). COVID-19 convalescent plasma cohort study: evaluation of the association between both donor and recipient neutralizing antibody titers and patient outcomes. Transfusion, 1-12. doi:10.1111/trf.16573 -
NLM
Yokoyama APH, Wendel S, Bub CB, Fachini RM, Dametto APF, Blumm F, Dutra VF, Candelaria GTP, Sakashita AM, Machado RRG, Wendel RF, Hamerschlak N, Achkar R, Assunção MSC, Scuracchio P, Nudelman V, Pastore L, Pinho JRR, Ben MD, Kalil Filho R, Marra AR, Amano MT, Kallás EG, Helito AS, Carvalho CRRD, Araujo DB, Durigon EL, Camargo AA, Rizzo LV, Reis LFL, Kutner JM. COVID-19 convalescent plasma cohort study: evaluation of the association between both donor and recipient neutralizing antibody titers and patient outcomes [Internet]. Transfusion. 2021 ; 1-12.[citado 2024 maio 02 ] Available from: https://doi.org/10.1111/trf.16573 -
Vancouver
Yokoyama APH, Wendel S, Bub CB, Fachini RM, Dametto APF, Blumm F, Dutra VF, Candelaria GTP, Sakashita AM, Machado RRG, Wendel RF, Hamerschlak N, Achkar R, Assunção MSC, Scuracchio P, Nudelman V, Pastore L, Pinho JRR, Ben MD, Kalil Filho R, Marra AR, Amano MT, Kallás EG, Helito AS, Carvalho CRRD, Araujo DB, Durigon EL, Camargo AA, Rizzo LV, Reis LFL, Kutner JM. COVID-19 convalescent plasma cohort study: evaluation of the association between both donor and recipient neutralizing antibody titers and patient outcomes [Internet]. Transfusion. 2021 ; 1-12.[citado 2024 maio 02 ] Available from: https://doi.org/10.1111/trf.16573 - Cross-lineage protection between chikv primary infection and mayv secondary exposure in mice
- Convalescent plasma for COVID-19 in hospitalised patients: an open-label, randomised clinical trial
- Screening for SARS‐CoV‐2 antibodies in convalescent plasma in Brazil: preliminary lessons from a voluntary convalescent donor program
- A longitudinal study of convalescent plasma (CCP) donors and correlation of ABO group, initial neutralizing antibodies (nAb), and body mass index (BMI) with nAb and anti‐nucleocapsid (NP) SARS‐CoV‐2 antibody kinetics: proposals for better quality of CCP collections
- Nebulized enriched heparin to treat no critical patients with Sars-Cov-2: triple-blind clinical trial
- Anti‐A and SARS‐CoV‐2: an intriguing association
- Surrogate test performance for SARS-CoV-2 neutralizing antibodies (nAbs) for convalescent plasma (CCP): how useful could they be?
- Soroprevalência da infecção pelos vírus Zika (ZIKV) e Dengue (DENV) em parturientes e transferência transplacentária de anticorpos anti-ZIKV e anti- DENV em neonatos na cidade de São Paulo, Brasil
- Skewed distribution of natural killer cells in psoriasis skin lesions [Carta]
- Patterns and Correlates of PrEP Drug Detection Among MSM and Transgender Women in the Global iPrEx Study
Informações sobre o DOI: 10.1111/trf.16573 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas